GJL
SEEL
Gendell Jeffrey L’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-428,966
| Closed | -$254K | – | 104 |
|
|
2024
Q1 | $254K | Buy |
428,966
+317,351
| +284% | +$188K | 0.01% | 86 |
|
|
2023
Q4 | $155K | Sell |
111,615
-6,632,970
| -98% | -$9.22M | 0.01% | 77 |
|
|
2023
Q3 | $1.24M | Buy |
6,744,585
+1,576,565
| +31% | +$290K | 0.07% | 63 |
|
|
2023
Q2 | $6.18M | Buy |
5,168,020
+100,000
| +2% | +$120K | 0.48% | 25 |
|
|
2023
Q1 | $3.5M | Buy |
5,068,020
+159,295
| +3% | +$110K | 0.33% | 37 |
|
|
2022
Q4 | $3.33M | Hold |
4,908,725
| – | – | 0.3% | 37 |
|
|
2022
Q3 | $5.06M | Hold |
4,908,725
| – | – | 0.66% | 23 |
|
|
2022
Q2 | $3.34M | Sell |
4,908,725
-24,299
| -0.5% | -$16.5K | 0.39% | 33 |
|
|
2022
Q1 | $4.13M | Buy |
4,933,024
+2,483,757
| +101% | +$2.08M | 0.3% | 36 |
|
|
2021
Q4 | $3.99M | Buy |
2,449,267
+589,632
| +32% | +$961K | 0.32% | 28 |
|
|
2021
Q3 | $4.48M | Buy |
1,859,635
+116,859
| +7% | +$282K | 0.38% | 28 |
|
|
2021
Q2 | $4.6M | Buy |
1,742,776
+517,532
| +42% | +$1.37M | 0.41% | 27 |
|
|
2021
Q1 | $6.11M | Buy |
+1,225,244
| New | +$6.11M | 0.65% | 18 |
|